U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07521384) titled 'Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy' on April 03.
Brief Summary: This prospective observational study collects real world data on participants receiving regenerative therapies administered internationally and delivered intranasally via the Kurve Therapeutics ViaNase device. The study does not assign treatment. Participants are enrolled after receiving, or electing to receive, therapy as part of routine clinical care outside the study.
Participants are observed in one of three cohorts based on the therapy received: MuSE cell derived exosomes, MuSE stem cells, or combin...